Try our Advanced Search for more refined results

Deals Rumor Mill: Shire, Monsanto, Lululemon

By Chelsea Naso (June 23, 2014, 2:32 PM EDT) -- London-listed drug maker Shire PLC has tapped Goldman Sachs to sharpen its defense skills as it prepares to confront another takeover offer, sources told the New York Times on Monday. Last week, Shire rejected a third takeover offer from U.S. pharmaceutical company AbbVie Inc. that valued it at about £27.2 billion ($46.3 billion) and expects the Chicago-based company to make a sweetened offer, the report said. The hiring of Goldman Sachs would also reduce the chances that Allergan might make its own bid for Shire due to a potential conflict of interest, as Goldman Sachs is advising Allergan in its defense against Valeant....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!